当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3812919
自主品牌
已选条件
-
T0755Carglumic Acid氨甲酰谷氨酸；Ureidoglutaric acid；N-Carbamylglutamate；Carbamylglutamic acid；N-Carbamyl-L-glut
Carglumic acid is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to ne
价 格：￥电议型 号：T0755产 地：中国大陆
-
T0755CarbagluCarbaglu,Carglumic Acid,N-Carbamyl-L-glutamic acid
Carglumic acid is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to ne
价 格：￥电议型 号：T0755产 地：美洲
-
T0755Carglumic Acid；氨甲酰谷氨酸Carbaglu|||N-Carbamylglutamate|||N-Carbamyl-L-glutamic acid|||Carbamylglutamic
Carglumic Acid (Ureidoglutaric acid) is an orphan drug used to treat hyperammonemia in patients with N-acetyl glutamate synthase absence. This rare hereditary disease results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and lead to neurologic problems, coma, cerebral edema, and death. Carglumic acid was approved by the U.S. FDA on 18 March 2010.
价 格：￥电议型 号：T0755产 地：中国大陆
